Sale!

Cultured AFB Antitubercular DST Rapid 10 Second Line Drugs Panel Test

Name: Cultured AFB Antitubercular DST Rapid 10 Second Line Drugs Panel Test
SKU: TEST-4892
Price: 2460 AED
Availability: InStock

Original price was: 2,730 د.إ.Current price is: 2,460 د.إ.

-10%

The “Cultured AFB Antitubercular DST Rapid 10 Second Line Drugs Panel Test” is a sophisticated diagnostic examination offered by DNA Labs UAE, specifically designed to evaluate the susceptibility of Mycobacterium tuberculosis strains to second-line antitubercular drugs. This test is crucial for patients who have tuberculosis (TB) that is resistant to first-line medications, a condition known as multidrug-resistant TB (MDR-TB). By analyzing cultured samples of the bacterium, the test quickly identifies which second-line drugs could effectively treat the infection, thus enabling healthcare providers to tailor treatment plans to the patient’s specific needs. The test costs 2460 AED and represents a vital tool in the fight against drug-resistant TB, ensuring that patients receive the most effective treatment in a timely manner. DNA Labs UAE, known for its state-of-the-art facilities and expertise in medical diagnostics, administers this test, contributing significantly to improved TB management and patient outcomes.

Description

CULTURED AFB ANTITUBERCULAR DST RAPID 10 SECOND LINE DRUGS PANEL Test

Test Name: CULTURED AFB ANTITUBERCULAR DST RAPID 10 SECOND LINE DRUGS PANEL Test

Components:

Amikacin
Kanamycin
Capreomycin
Clofazimine
Ethionamide
Ofloxacin
Levofloxacin
Moxifloxacin
PAS
Cycloserine

Price: 2460.0 AED

Sample Condition: Submit pure growth of Mycobacterium tuberculosis complex on appropriate media in sterile screw capped container in a sealed plastic bag. Ship refrigerated OR when used with other AFB culture or Mycobacteria identification tests, the pure growth obtained in the Laboratory from specimens already submitted will be processed for Antitubercular Sensitivity.

Report Delivery: Sample Daily by 3.30 pm; Report 21 days

Method: Automated Fluorescent

Test Type: Tuberculosis

Doctor: Physician

Test Department:

Pre Test Information: No special preparation required

Test Details:

The CULTURED AFB ANTITUBERCULAR DST RAPID 10 SECOND LINE DRUGS PANEL test is a diagnostic test used to determine the drug susceptibility of Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB). This test specifically looks at the susceptibility of the bacteria to second-line drugs, which are used when the bacteria are resistant to first-line drugs.

The test involves culturing a sample of the bacteria and exposing it to a panel of ten second-line drugs commonly used to treat drug-resistant TB. The drugs included in the panel may vary depending on the specific laboratory or test kit used, but commonly include drugs such as amikacin, capreomycin, kanamycin, linezolid, moxifloxacin, and others.

The test evaluates the growth of the bacteria in the presence of each drug, determining whether the bacteria are susceptible or resistant to each drug. This information is crucial in guiding the choice of appropriate antibiotics for the treatment of drug-resistant TB.

The “RAPID” in the test name suggests that the results are obtained relatively quickly, typically within 10 seconds, although this may vary depending on the specific testing method used.

Overall, the CULTURED AFB ANTITUBERCULAR DST RAPID 10 SECOND LINE DRUGS PANEL test is an important tool in the management of drug-resistant TB, helping to guide the selection of effective treatment options for patients.

Test Name	CULTURED AFB ANTITUBERCULAR DST RAPID 10 SECOND LINE DRUGS PANEL Test
Components	AmikacinKanamycinCapreomycinClofazimineEthionamideOfloxacinLevofloxacinMoxifloxacinPAS Cycloserine
Price	2460.0 AED
Sample Condition	Submit pure growth ofMycobacterium tuberculosis complexon appropriate media in sterile screw capped container in a sealed plastic bag. Ship refrigeratedOR when used with other AFB culture or Mycobacteria identification tests the pure growth obtained in the Laboratory from specimens already submittedwill be processed for Antitubercular Sensitivity.
Report Delivery	Sample Daily by 3.30 pm; Report 21 days
Method	Automated Fluorescent
Test type	Tuberculosis
Doctor	Physician
Test Department:
Pre Test Information	No special preparation required
Test Details	The CULTURED AFB ANTITUBERCULAR DST RAPID 10 SECOND LINE DRUGS PANEL test is a diagnostic test used to determine the drug susceptibility of Mycobacterium tuberculosis, the bacteria that causes tuberculosis (TB). This test specifically looks at the susceptibility of the bacteria to second-line drugs, which are used when the bacteria are resistant to first-line drugs. The test involves culturing a sample of the bacteria and exposing it to a panel of ten second-line drugs commonly used to treat drug-resistant TB. The drugs included in the panel may vary depending on the specific laboratory or test kit used, but commonly include drugs such as amikacin, capreomycin, kanamycin, linezolid, moxifloxacin, and others. The test evaluates the growth of the bacteria in the presence of each drug, determining whether the bacteria are susceptible or resistant to each drug. This information is crucial in guiding the choice of appropriate antibiotics for the treatment of drug-resistant TB. The “RAPID” in the test name suggests that the results are obtained relatively quickly, typically within 10 seconds, although this may vary depending on the specific testing method used. Overall, the CULTURED AFB ANTITUBERCULAR DST RAPID 10 SECOND LINE DRUGS PANEL test is an important tool in the management of drug-resistant TB, helping to guide the selection of effective treatment options for patients.